{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:49:28Z","timestamp":1780390168986,"version":"3.54.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>We comprehensively assessed patient survival and the duration of peritoneal dialysis (PD) treatment over a 25-year period within our PD unit.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We retrospectively evaluated 497 PD patients who initiated PD between 1996 and 2021. The cohort was divided into three distinct periods based on pivotal events, such as the introduction of more biocompatible dialysis solutions and the initiation of remote monitoring technologies. Kaplan\u2013Meier survival assessments, Cox proportional hazards model and Gray subdistribution hazard model were employed to evaluate patient survival and PD-to-hemodialysis (HD) transfer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The use of PD as the initial treatment increased significantly over the years. Mean age was 63.5\u00a0\u00b1\u00a015.7 years; 61% were male, and 61% had three or more comorbidities including hypertension (81%), dyslipidemia (66%), cardiovascular disease (56%) and diabetes (16%). The five-year mortality rate was 40%. Risk factors for mortality included continuous ambulatory peritoneal dialysis (CAPD) [hazard ratio (HR)\u00a0=\u00a02.63, 95% confidence interval (CI) 1.76\u20133.93; P\u00a0&amp;lt;\u00a0.001], older age (HR\u00a0=\u00a02.96, 95% CI 1.98\u20134.43; P\u00a0&amp;lt;\u00a0.001), cardiovascular disease (HR\u00a0=\u00a01.96, 95% CI 1.31\u20132.95; P\u00a0=\u00a0.001) and the use of renin\u2013angiotensin\u2013aldosterone system inhibitors (RAASi) (HR\u00a0=\u00a01.81, 95% CI 1.22\u20132.70; P\u00a0=\u00a0.004). At 5 years, 48% of patients remained on PD. In the Cox model, risk factors for PD-to-HD transfer included CAPD (HR\u00a0=\u00a01.62, 95% CI 1.21\u20132.16; P\u00a0=\u00a0.001). RAASi use (HR\u00a0=\u00a00.66, 95% CI 0.46\u20130.94; P\u00a0=\u00a0.02) and female sex (HR\u00a0=\u00a00.70, 95% CI 0.51\u20130.96; P\u00a0=\u00a0.03) were associated with longer PD duration.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The study provides insights into the changing landscape of PD. Advances in PD solutions and remote monitoring have contributed to changes in PD outcomes and its increased adoption over the years. Given the observational nature of the study, caution is warranted in interpreting the association of both CAPD and RAASi with mortality.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfaf215","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T11:34:07Z","timestamp":1751974447000},"source":"Crossref","is-referenced-by-count":6,"title":["Long-term mortality and technique survival in peritoneal dialysis patients: a 25-year retrospective analysis in a single center"],"prefix":"10.1093","volume":"18","author":[{"given":"Roberta","family":"Scarmignan","sequence":"first","affiliation":[{"name":"Oncology and Regenerative Medicine (CHIMOMO), Section of Nephrology, University of Modena and Reggio Emilia Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0591-8622","authenticated-orcid":false,"given":"Gaetano","family":"Alfano","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis and Kidney Transplant Unit, Azienda Ospedaliero Universitaria di Modena , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Morisi","sequence":"additional","affiliation":[{"name":"Oncology and Regenerative Medicine (CHIMOMO), Section of Nephrology, University of Modena and Reggio Emilia Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0762-0942","authenticated-orcid":false,"given":"Francesco","family":"Fontana","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis and Kidney Transplant Unit, Azienda Ospedaliero Universitaria di Modena , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Mori","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis and Kidney Transplant Unit, Azienda Ospedaliero Universitaria di Modena , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ferrarini","sequence":"additional","affiliation":[{"name":"Oncology and Regenerative Medicine (CHIMOMO), Section of Nephrology, University of Modena and Reggio Emilia Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Ferri","sequence":"additional","affiliation":[{"name":"Oncology and Regenerative Medicine (CHIMOMO), Section of Nephrology, University of Modena and Reggio Emilia Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tonelli","sequence":"additional","affiliation":[{"name":"Oncology and Regenerative Medicine (CHIMOMO), Section of Nephrology, University of Modena and Reggio Emilia Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ligabue","sequence":"additional","affiliation":[{"name":"Oncology and Regenerative Medicine (CHIMOMO), Section of Nephrology, University of Modena and Reggio Emilia Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Magistroni","sequence":"additional","affiliation":[{"name":"Oncology and Regenerative Medicine (CHIMOMO), Section of Nephrology, University of Modena and Reggio Emilia Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, , Modena ,","place":["Italy"]},{"name":"Nephrology, Dialysis and Kidney Transplant Unit, Azienda Ospedaliero Universitaria di Modena , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariacristina","family":"Gregorini","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, AUSL-IRCCS , Arcispedale S. Maria Nuova Reggio Emilia, Reggio Emilia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Donati","sequence":"additional","affiliation":[{"name":"Oncology and Regenerative Medicine (CHIMOMO), Section of Nephrology, University of Modena and Reggio Emilia Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, , Modena ,","place":["Italy"]},{"name":"Nephrology, Dialysis and Kidney Transplant Unit, Azienda Ospedaliero Universitaria di Modena , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"2025080406164325800_bib1","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1046\/j.1523-1755.1998.00180.x","article-title":"What really happens to people on long-term peritoneal dialysis?","volume":"54","author":"Davies","year":"1998","journal-title":"Kidney Int"},{"key":"2025080406164325800_bib2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"2025080406164325800_bib3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"2025080406164325800_bib4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1053\/ajkd.2002.33916","article-title":"How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices","volume":"40","author":"Van Manen","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"2025080406164325800_bib5","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/ndt\/17.6.1085","article-title":"Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival","volume":"17","author":"Davies","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"2025080406164325800_bib6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.34067\/KID.0007692021","article-title":"Hidden costs associated with conversion from peritoneal dialysis to hemodialysis","volume":"3","author":"Weinhandl","year":"2022","journal-title":"Kidney360"},{"key":"2025080406164325800_bib7","first-page":"2023","article-title":"Peritoneal dialysis in Italy: the 8th GPDP-SIN census 2022","volume":"40","author":"Neri","year":"2023","journal-title":"G Ital Nefrol"},{"key":"2025080406164325800_bib8","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1046\/j.1523-1755.1999.00353.x","article-title":"Mortality and technique failure in patients starting chronic peritoneal dialysis: results of the Netherlands Cooperative Study on the Adequacy of dialysis","volume":"55","author":"Jager","year":"1999","journal-title":"Kidney Int"},{"key":"2025080406164325800_bib9","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3747\/pdi.2012.00111","article-title":"Better outcomes of peritoneal dialysis in diabetic patients in spite of risk of loss of autonomy for home dialysis","volume":"34","author":"Cotovio","year":"2014","journal-title":"Perit Dial Int"},{"key":"2025080406164325800_bib10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1046\/j.1523-1755.2000.00184.x","article-title":"Peritoneal dialysis adequacy and risk of death","volume":"58","author":"Rocco","year":"2000","journal-title":"Kidney Int"},{"key":"2025080406164325800_bib11","first-page":"1905","article-title":"Prognostic factors in CAPD patients: a retrospective study of a ten-year period","volume":"10","author":"Genestier","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"2025080406164325800_bib12","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1046\/j.1525-139X.2002.00106.x","article-title":"APD in the elderly","volume":"15","author":"Kadambi","year":"2002","journal-title":"Semin Dial"},{"key":"2025080406164325800_bib13","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/ki.1996.194","article-title":"Impact of hypertension on cardiomyopathy, morbidity, and mortality in end-stage renal disease","volume":"49","author":"Foley","year":"1996","journal-title":"Kidney Int"},{"key":"2025080406164325800_bib14","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/S0140-6736(00)03123-8","article-title":"Clinical outcomes, quality of life and costs in the North Thames Dialysis Study of elderly people on dialysis: a prospective cohort study","volume":"356","author":"Lamping","year":"2000","journal-title":"Lancet"},{"key":"2025080406164325800_bib15","first-page":"164","article-title":"The impact of co-morbid risk factors at the start of dialysis upon the survival of ESRD patients","volume":"42","author":"Mailloux","year":"1996","journal-title":"ASAIO J"},{"key":"2025080406164325800_bib16","first-page":"6867","article-title":"Comorbidity and in-hospital mortality in peritoneal dialysis patients: data of the Emilia Romagna region of Italy","volume":"27","author":"Fabbian","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2025080406164325800_bib17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1046\/j.1523-1755.1998.00005.x","article-title":"\u201cU\u201d curve association of blood pressure and mortality in hemodialysis patients","volume":"54","author":"Zager","year":"1998","journal-title":"Kidney Int"},{"key":"2025080406164325800_bib18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12916-021-01963-0","article-title":"Variation in hypertension clinical practice guidelines: a global comparison","volume":"19","author":"Philip","year":"2021","journal-title":"BMC Med"},{"key":"2025080406164325800_bib19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1046\/j.1523-1755.2003.00803.x","article-title":"Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients","volume":"63","author":"Kalantar-Zadeh","year":"2003","journal-title":"Kidney Int"},{"key":"2025080406164325800_bib20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000491552","article-title":"Use of renin-angiotensin system blockers increases serum potassium in anuric hemodialysis patients","volume":"48","author":"Movilli","year":"2018","journal-title":"Am J Nephrol"},{"key":"2025080406164325800_bib21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000479011","article-title":"Impact of renin-angiotensin aldosterone system inhibition on serum potassium levels among peritoneal dialysis patients","volume":"46","author":"Ribeiro","year":"2017","journal-title":"Am J Nephrol"},{"key":"2025080406164325800_bib22","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1097\/00005344-199106182-00027","article-title":"Dose-response relationship of ramipril in patients with mild-to-moderate hypertension","volume":"18","author":"Schnaper","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"2025080406164325800_bib23","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0272-6386(99)70181-2","article-title":"A subdepressor low dose of ramipril lowers urinary protein excretion without increasing plasma potassium","volume":"33","author":"Keilani","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"2025080406164325800_bib24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.7326\/0003-4819-139-2-200307150-00010","article-title":"Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study","volume":"139","author":"Li","year":"2003","journal-title":"Ann Intern Med"},{"key":"2025080406164325800_bib25","first-page":"CD007554","article-title":"Biocompatible dialysis fluids for peritoneal dialysis","volume":"10","author":"Htay","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2025080406164325800_bib26","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/ndt\/gfae188","article-title":"Remote monitoring of automated peritoneal dialysis reduces mortality, adverse events and hospitalizations: a cluster-randomized controlled trial","volume":"40","author":"Paniagua","year":"2025","journal-title":"Nephrol Dial Transplant"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfaf215\/63704006\/sfaf215.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/8\/sfaf215\/63704006\/sfaf215.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/8\/sfaf215\/63704006\/sfaf215.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T10:16:49Z","timestamp":1754302609000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfaf215\/8193697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfaf215","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,7,8]]},"article-number":"sfaf215"}}